Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Therapy in Impacted Mandibular Third Molar Surgery
NCT07817940Phase 4Completed
- Sponsor
- Bolu Abant Izzet Baysal University
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin + clavulanate in Impacted Mandibular Third Molar (IM3M) (3 arms), sponsored by Bolu Abant Izzet Baysal University. Primary endpoint: Change in Serum C-Reactive Protein Level at Day 7. Started Nov 2023; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Impacted Mandibular Third Molar (IM3M)
Beyond the preview
Go deeper on NCT07817940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07817940.